If a patient requests more information on therapies that involve the manipulation of the body's energy fields, which method should the nurse discuss? (Select all that apply)

Choice A reason: While tardive dyskinesia is a serious concern with many antipsychotics, clozapine is actually associated with a very low risk of this condition. In fact, clozapine is often used as a treatment strategy for patients who have already developed severe tardive dyskinesia from other neuroleptic medications.

Choice B reason: Clozapine has a unique pharmacological profile with low D2 receptor occupancy in the striatum, making extrapyramidal symptoms like tremors or rigidity highly unlikely. It is specifically chosen for patients who are treatment-resistant or highly sensitive to the motor side effects caused by other typical or atypical antipsychotics.

Choice C reason: Serotonin syndrome is a toxic state caused by excessive serotonergic activity, usually resulting from interactions between SSRIs, SNRIs, or MAOIs. While clozapine affects various neurotransmitter systems, it is not primarily associated with the development of serotonin syndrome, which presents with hyperreflexia, clonus, and autonomic instability.

Choice D reason: Agranulocytosis is a life-threatening reduction in the white blood cell count (specifically neutrophils) that can occur in patients taking clozapine. This requires strict mandatory blood monitoring of the Absolute Neutrophil Count (ANC) to prevent severe sepsis or death, making it the most critical safety priority for the nurse.

Choice A reason: Acute dystonia involves sudden, involuntary muscle contractions often resulting in abnormal posturing, such as torticollis or oculogyric crisis. While it involves muscle tension, it is typically more spasmodic and localized than the generalized rigidity and slowed movements that characterize the parkinsonian-like side effects seen during routine therapy check-ups.

Choice B reason: Pseudoparkinsonism is induced by the blockade of dopamine D2 receptors in the nigrostriatal pathway, mimicking the symptoms of Parkinson's disease. This manifests as generalized muscle rigidity, a shuffling gait, tremors, and bradykinesia. It is a common subacute reaction that develops within days to weeks of starting an antipsychotic.

Choice C reason: Tardive dyskinesia is characterized by hyperkinetic movements rather than rigidity. It usually develops after months or years of neuroleptic use. The pathophysiology involves dopamine receptor supersensitivity, leading to uncontrollable movements like lip smacking, which is the functional opposite of the stiff, rigid muscles described in this specific clinical scenario.

Choice D reason: Akathisia presents as a profound sense of restlessness and an inability to sit still. Patients often describe feeling like they are "jumping out of their skin." This condition is characterized by excessive motor activity and subjective agitation rather than the physical stiffness or rigidity found in pseudoparkinsonism.